Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro

Bisphosphonates (BPs) are an emerging class of drugs mostly used in the palliative care of cancer patients. We investigated the in vitro activity of the most potent antiresorptive BP, zoledronic acid (ZOL), on the growth and survival of three human pancreatic cancer (PC) cell lines (BxPC-3, CFPAC-1...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tassone, P, Tagliaferri, P, Viscomi, C, Palmieri, C, Caraglia, M, D'Alessandro, A, Galea, E, Goel, A, Abbruzzese, A, Boland, C R, Venuta, S
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2003
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2741108/
https://ncbi.nlm.nih.gov/pubmed/12799645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600986
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires